Invention Grant
- Patent Title: 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
-
Application No.: US17308740Application Date: 2021-05-05
-
Publication No.: US11691963B2Publication Date: 2023-07-04
- Inventor: Craig E. Masse , Jeremy R. Greenwood , Sayan Mondal , Jiayi Xu , Phani Ghanakota , Fiona Michelle McRobb , Nicholas Boyles
- Applicant: Ajax Therapeutics, Inc.
- Applicant Address: US NY New York
- Assignee: Ajax Therapeutics, Inc.
- Current Assignee: Ajax Therapeutics, Inc.
- Current Assignee Address: US NY New York
- Agency: Choate, Hall & Stewart LLP
- Agent John P. Rearick; Erica M. D'Amato
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/12 ; C07D405/14 ; C07D413/14 ; C07D417/14 ; C07D471/04
Abstract:
The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.
Public/Granted literature
- US20220411403A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS Public/Granted day:2022-12-29
Information query
